Table of Content



Chapter 1 Scaffold Technology Market: Methodology and Scope
1.1 Information Procurement
1.1.1 Purchased database
1.1.2 GVR’s internal database
1.1.3 Secondary sources
1.1.4 Third party perspective
1.1.5 Primary research
1.2 Data Analysis
1.3 Market Formulation & Validation
1.4 Region Wise Market Calculation & Scope
1.4.1 Market scope: by application
1.4.2 Region wise market: Base estimates
1.4.3 Global market: CAGR calculation
1.4.4 Region based segment share calculation
Chapter 2 Scaffold Technology Market: Executive Summary
2.1 Market Summary, 2019
Chapter 3 Scaffold Technology Market: Market Variables, Trends, and Scope
3.1 Scaffold technology Market: Segment Outlook, 2016 - 2027
3.1.1 Market driver analysis
3.1.1.1 Increasing demand for 3D cellular models in translational research
3.1.1.2 Increasing demand for body reconstruction procedures and tissue engineering
3.1.1.3 Advancements in scaffold technology
3.1.2 Market restraint analysis
3.1.2.1 Introduction of scaffold-free technology for 3D cell culture
3.1.2.2 Lack of consistency in generated results
3.2 Penetration & Growth Prospect Mapping for Type, 2019
3.3 Scaffold Technology Market-SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis - Porter’s
Chapter 4 Scaffold Technology Market: Type Estimates and Trend Analysis
4.1 Scaffold Technology Market: Type Movement Analysis, 2019 & 2027
4.2 Hydrogels
4.2.1 Scaffold technology market for hydrogels, 2016 - 2027 (USD Million)
4.2.2 Hydrogels, by application
4.2.2.1 Wound healing
4.2.3 Hydrogels market for wound healing, 2016 - 2027 (USD Million)
4.2.3.1 3D bioprinting
4.2.4 Hydrogels market for 3D bioprinting, 2016 - 2027 (USD Million)
4.2.4.1 Immunomodulation
4.2.5 Hydrogels market for immunomodulation, 2016 - 2027 (USD Million)
4.3 Polymeric Scaffolds
4.3.1 Scaffold technology market for polymeric scaffolds, 2016 - 2027 (USD Million)
4.4 Micropatterned Surface Microplates
4.4.1 Scaffold technology market for micropatterned surface microplates, 2016 - 2027 (USD Million)
4.5 Nanofiber-Based Scaffolds
4.5.1 Scaffold technology market for nanofiber-based scaffolds, 2016 - 2027 (USD Million)
Chapter 5 Scaffold Technology Market: Application Business Analysis
5.1 Scaffold Technology Market: Application Movement Analysis, 2019 & 2027
5.2 Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering
5.2.1 Cell encapsulations for regenerative medicine
5.2.2 Scaffold technology market for stem cell therapy, regenerative medicine, & tissue engineering, 2016 - 2027 (USD Million)
5.3 Drug Discovery
5.3.1 Scaffold technology market for drug discovery, 2016 - 2027 (USD Million)
5.4 Others
5.4.1 Scaffold technology market for others, 2016 - 2027 (USD Million)
Chapter 6 Scaffold Technology Market: Disease Type Estimates and Trend Analysis
6.1 Scaffold Technology Market: Disease Type Movement Analysis, 2019 & 2027
6.2 Orthopedics, Musculoskeletal, & Spine
6.2.1 Scaffold technology market for orthopedics, musculoskeletal, & spine, 2016 - 2027 (USD Million)
6.3 Cancer
6.3.1 Analysis of Extracellular Matrix (ECM) scaffolds and nanotechnology-based strategies for cancer diagnosis and prognosis
6.3.2 Scaffold technology market for cancer, 2016 - 2027 (USD Million)
6.4 Skin & Integumentary
6.4.1 Scaffold technology market for skin & integumentary, 2016 - 2027 (USD Million)
6.5 Dental
6.5.1 Strategies for developing new smart tissue engineering scaffolds for dentine_pulp complex regeneration
6.5.2 Scaffold technology market for dental, 2016 - 2027 (USD Million)
6.6 Cardiology & Vascular
6.6.1 Scaffold technology market for cardiology & vascular, 2016 - 2027 (USD Million)
6.7 Neurology
6.7.1 Scaffold technology market for neurology, 2016 - 2027 (USD Million)
6.8 Urology
6.8.1 Scaffold technology market for urology, 2016 - 2027 (USD Million)
6.9 Gastrointestinal Disorders (GI) & Gynecology
6.9.1 Scaffold technology market for GI & gynecology, 2016 - 2027 (USD Million)
6.10 Others
6.10.1 Scaffold technology market for other disease types, 2016 - 2027 (USD Million)
Chapter 7 Scaffold Technology Market: End-use Estimates and Trend Analysis
7.1 Scaffold Technology Market: End-use Movement Analysis, 2019 & 2027
7.2 Biotechnology and Pharmaceutical Organizations
7.2.1 Scaffold technology market for biotechnology and pharmaceutical organizations, 2016 - 2027 (USD Million)
7.3 Research Laboratories and Institutes
7.3.1 Scaffold technology market for research laboratories and institutes, 2016 - 2027 (USD Million)
7.4 Hospitals and Diagnostic Centers
7.4.1 Scaffold technology market for hospitals and diagnostic centers, 2016 - 2027 (USD Million)
7.5 Others
7.5.1 Scaffold technology market for others, 2016 - 2027 (USD Million)
Chapter 8 Scaffold Technology Market: Region Business Analysis
8.1 Scaffold Technology Market: Regional Movement Analysis, 2019 & 2027
8.2 North America
8.2.1 North America scaffold technology market estimates and forecast, 2016 - 2027 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. scaffold technology market estimates and forecast, by type, 2016 - 2027 (USD Million)
8.2.2.2 U.S. scaffold technology market estimates and forecast, by application, 2016 - 2027 (USD Million)
8.2.2.3 U.S. scaffold technology market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
8.2.2.4 U.S. scaffold technology market estimates and forecast, by end use, 2016 - 2027 (USD Million)
8.2.3 Canada
8.2.3.1 Canada scaffold technology market estimates and forecast, by type, 2016 - 2027 (USD Million)
8.2.3.2 Canada scaffold technology market estimates and forecast, by application, 2016 - 2027 (USD Million)
8.2.3.3 Canada scaffold technology market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
8.2.3.4 Canada scaffold technology market estimates and forecast, by end use, 2016 - 2027 (USD Million)
8.3 Europe
8.3.1 Europe scaffold technology market estimates and forecast, 2016 - 2027 (USD Million)
8.3.2 Germany
8.3.2.1 Germany scaffold technology market estimates and forecast, by type, 2016 - 2027 (USD Million)
8.3.2.2 Germany scaffold technology market estimates and forecast, by application, 2016 - 2027 (USD Million)
8.3.2.3 Germany scaffold technology market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
8.3.2.4 Germany scaffold technology market estimates and forecast, by end use, 2016 - 2027 (USD Million)
8.3.3 U.K.
8.3.3.1 U.K. scaffold technology market estimates and forecast, by type, 2016 - 2027 (USD Million)
8.3.3.2 U.K. scaffold technology market estimates and forecast, by application, 2016 - 2027 (USD Million)
8.3.3.3 U.K. scaffold technology market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
8.3.3.4 U.K. scaffold technology market estimates and forecast, by end use, 2016 - 2027 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific scaffold technology market estimates and forecast, 2016 - 2027 (USD Million)
8.4.2 Japan
8.4.2.1 Japan scaffold technology market estimates and forecast, by type, 2016 - 2027 (USD Million)
8.4.2.2 Japan scaffold technology market estimates and forecast, by application, 2016 - 2027 (USD Million)
8.4.2.3 Japan scaffold technology market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
8.4.2.4 Japan scaffold technology market estimates and forecast, by end use, 2016 - 2027 (USD Million)
8.4.3 China
8.4.3.1 China scaffold technology market estimates and forecast, by type, 2016 - 2027 (USD Million)
8.4.3.2 China scaffold technology market estimates and forecast, by application, 2016 - 2027 (USD Million)
8.4.3.3 China scaffold technology market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
8.4.3.4 China scaffold technology market estimates and forecast, by end use, 2016 - 2027 (USD Million)
8.5 Latin America
8.5.1 Latin America scaffold technology market estimates and forecast, 2016 - 2027 (USD Million)
8.5.2 Brazil
8.5.3.1 Brazil scaffold technology market estimates and forecast, by type, 2016 - 2027 (USD Million)
8.5.3.2 Brazil scaffold technology market estimates and forecast, by application, 2016 - 2027 (USD Million)
8.5.3.3 Brazil scaffold technology market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
8.5.3.4 Brazil scaffold technology market estimates and forecast, by end use, 2016 - 2027 (USD Million)
8.6 Middle East and Africa (MEA)
8.6.1 MEA scaffold technology market estimates and forecast, 2016 - 2027 (USD Million)
8.6.2 South Africa
8.6.3.1 South Africa scaffold technology market estimates and forecast, by type, 2016 - 2027 (USD Million)
8.6.3.2 South Africa scaffold technology market estimates and forecast, by application, 2016 - 2027 (USD Million)
8.6.3.3 South Africa scaffold technology market estimates and forecast, by disease type, 2016 - 2027 (USD Million)
8.6.3.4 South Africa scaffold technology market estimates and forecast, by end use, 2016 - 2027 (USD Million)
Chapter 9 Scaffold Technology Market: Company Profile
9.1 Strategy Framework
9.2 Market Participation Categorization
9.3 Company Profiles
9.3.1 Merck KGaA
9.3.1.1 Company Overview
9.3.1.2 Sigma-Aldrich, Inc.
9.3.1.2.1 Company Overview
9.3.1.3 Merck Millipore
9.3.1.3.1 Company Overview
9.3.1.4 Financial Performance
9.3.1.5 Product Benchmarking
9.3.1.6 Strategic Initiatives
9.3.2 Thermo Fisher Scientific, Inc.
9.3.2.1 Company Overview
9.3.2.2 Financial Performance
9.3.2.3 Product Benchmarking
9.3.2.4 Strategic Initiatives
9.3.3 BD (Becton, Dickinson and Company)
9.3.3.1 Company Overview
9.3.3.2 Financial Performance
9.3.3.3 Product Benchmarking
9.3.4 3D Biotek LLC
9.3.4.1 Company Overview
9.3.4.2 Financial Performance
9.3.4.3 Product Benchmarking
9.3.4.4 Strategic Initiatives
9.3.5 Molecular Matrix, Inc.
9.3.5.1 Company Overview
9.3.5.2 Financial Performance
9.3.5.3 Product Benchmarking
9.3.5.4 Strategic Initiatives
9.3.6 REPROCELL, Inc.
9.3.6.1 Company Overview
9.3.6.2 Financial Performance
9.3.6.3 Product Benchmarking
9.3.6.4 Strategic Initiatives
9.3.7 Xanofi
9.3.7.1 Company Overview
9.3.7.2 Product Benchmarking
9.3.7.3 Strategic Initiatives
9.3.8 Tecan Trading AG
9.3.8.1 Company Overview
9.3.8.2 Financial Performance
9.3.8.3 Product Benchmarking
9.3.8.4 Strategic Initiatives
9.3.9 Matricel GmbH
9.3.9.1 Company Overview
9.3.9.2 Financial Performance
9.3.9.3 Product Benchmarking
9.3.9.4 Strategic Initiatives
9.3.10 Pelobiotech
9.3.10.1 Company Overview
9.3.10.2 Financial Performance
9.3.10.3 Product Benchmarking
9.3.11 Corning Incorporated
9.3.11.1 Company Overview
9.3.11.2 Financial Performance
9.3.11.3 Product Benchmarking
9.3.11.4 Strategic Initiatives
9.3.12 Akron Biotech
9.3.12.1 Company Overview
9.3.12.2 Financial Performance
9.3.12.3 Product Benchmarking
9.3.12.4 Strategic Initiatives
9.3.13 4titude
9.3.13.1 Company Overview
9.3.13.2 Financial Performance
9.3.13.3 Product Benchmarking
9.3.14 3D Biomatrix
9.3.14.1 Company Overview
9.3.14.2 Product Benchmarking
9.3.15 Nanofiber Solutions
9.3.15.1 Company Overview
9.3.15.2 Financial Performance
9.3.15.3 Product Benchmarking
9.3.15.4 Strategic Initiatives
9.3.16 NuVasive, Inc.
9.3.16.1 Company Overview
9.3.16.2 Financial Performance
9.3.16.3 Product Benchmarking
9.3.16.4 Strategic Initiatives
9.3.17 Avacta Life Sciences Limited
9.3.17.1 Company Overview
9.3.17.2 Financial Performance
9.3.17.3 Product Benchmarking
9.3.17.4 Strategic Initiatives
9.3.18 Medtronic
9.3.18.1 Company Overview
9.3.18.2 Financial Performance
9.3.18.3 Product Benchmarking
9.3.18.4 Strategic Initiatives
9.3.19 Allergan
9.3.19.1 Company Overview
9.3.19.2 LifeCell Corporation
9.3.19.2.1 Company Overview
9.3.19.3 Financial Performance
9.3.19.4 Product Benchmarking
9.3.19.5 Strategic Initiatives
9.3.20 Vericel Corporation
9.3.20.1 Company Overview
9.3.20.2 Financial Performance
9.3.20.3 Product Benchmarking
9.3.20.4 Strategic Initiatives



List of Tables



TABLE 1 Country share estimation
TABLE 2 Comparative performance analysis of different 3D cell culture techniques
TABLE 3 Comparative performance analysis of commercially available sca_olds-based 3D culture systems
TABLE 4 Classification of the scaffold fabrication technologies
TABLE 5 Comparison of different drug loading strategies for chitosan-based hydrogels
TABLE 6 Comparison of commonly used non-functionalized bio-inks
TABLE 7 List of some of the commercially available polymeric scaffold products
TABLE 8 Hydrogels used for drug delivery
TABLE 9 Bioactive components of ECM scaffolds that play a role in constructive tissue remodeling outcomes
TABLE 10 ECM-derived molecules in cancer diagnosis
TABLE 11 Biomaterials_based scaffolds for regeneration of the dentin_pulp complex
TABLE 12 Scaffolds for neurology
TABLE 13 Scaffolds used as tubular urethral substitutes
TABLE 14 Preclinical and human studies evaluating the use of ECM bio-scaffolds to repair GI tissue
TABLE 15 Biomaterials used for corneal bioengineering
TABLE 16 North America scaffold technology market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 17 North America hydrogel scaffold technology market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 18 North America scaffold technology market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 19 North America scaffold technology market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
TABLE 20 North America scaffold technology market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
TABLE 21 U.S. scaffold technology market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 22 U.S. hydrogel scaffold technology market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 23 U.S. scaffold technology market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 24 U.S. scaffold technology market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
TABLE 25 U.S. scaffold technology market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
TABLE 26 Canada scaffold technology market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 27 Canada hydrogel scaffold technology market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 28 Canada scaffold technology market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 29 Canada scaffold technology market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
TABLE 30 Canada scaffold technology market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
TABLE 31 Europe scaffold technology market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 32 Europe hydrogel scaffold technology market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 33 Europe scaffold technology market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 34 Europe scaffold technology market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
TABLE 35 Europe scaffold technology market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
TABLE 36 Germany scaffold technology market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 37 Germany hydrogel scaffold technology market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 38 Germany scaffold technology market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 39 Germany scaffold technology market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
TABLE 40 Germany scaffold technology market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
TABLE 41 U.K. scaffold technology market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 42 U.K. hydrogel scaffold technology market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 43 U.K. scaffold technology market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 44 U.K. scaffold technology market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
TABLE 45 U.K. scaffold technology market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
TABLE 46 Asia Pacific scaffold technology market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 47 Asia Pacific hydrogel scaffold technology market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 48 Asia Pacific scaffold technology market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 49 Asia Pacific scaffold technology market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
TABLE 50 Asia Pacific scaffold technology market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
TABLE 51 Japan scaffold technology market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 52 Japan hydrogel scaffold technology market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 53 Japan scaffold technology market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 54 Japan scaffold technology market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
TABLE 55 Japan scaffold technology market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
TABLE 56 China scaffold technology market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 57 China hydrogel scaffold technology market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 58 China scaffold technology market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 59 China scaffold technology market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
TABLE 60 China scaffold technology market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
TABLE 61 Latin America scaffold technology market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 62 Latin America hydrogel scaffold technology market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 63 Latin America scaffold technology market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 64 Latin America scaffold technology market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
TABLE 65 Latin America scaffold technology market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
TABLE 66 Brazil scaffold technology market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 67 Brazil hydrogel scaffold technology market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 68 Brazil scaffold technology market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 69 Brazil scaffold technology market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
TABLE 70 Brazil scaffold technology market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
TABLE 71 MEA scaffold technology market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 72 MEA hydrogel scaffold technology market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 73 MEA scaffold technology market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 74 MEA scaffold technology market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
TABLE 75 MEA scaffold technology market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
TABLE 76 South Africa scaffold technology market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 77 South Africa hydrogel scaffold technology market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 78 South Africa scaffold technology market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 79 South Africa scaffold technology market estimates & forecasts, by disease type, 2016 - 2027 (USD Million)
TABLE 80 South Africa scaffold technology market estimates & forecasts, by end use, 2016 - 2027 (USD Million)